Obstructive sleep apnoea and right ventricular function: A combined assessment by speckle tracking and three-dimensional echocardiography by Buonauro, Agostino et al.
Obstructive sleep apnoea and right ventricular function: A combined
assessment by speckle tracking and three-dimensional echocardiography
Agostino Buonauro a, Maurizio Galderisi a,⁎, Ciro Santoro a, Angelo Canora b, Maria Luisa Bocchino b,
Francesco Lo Iudice a, Maria Lembo a, Roberta Esposito a, Sabrina Castaldo b,
Bruno Trimarco a, Alessandro Sanduzzi b
a Department of Advanced Biomedical Sciences, Federico II University Hospital, Naples, Italy
b Department of Clinical Medicine and Surgery, Federico II University Hospital, Naples, Italy
a b s t r a c ta r t i c l e i n f o
Article history:
Received 27 February 2017
Received in revised form 4 April 2017
Accepted 2 May 2017
Available online xxxx
Background: Little is known on right ventricular (RV) involvement in obstructive sleep apnoea (OSA). This study
aimed at evaluating early RV dysfunction by standard and advanced echocardiography in OSA.
Methods: Fifty-nineOSA patientswithout heart failure and29 age-matched controls underwent standard, speckle
tracking and real time 3D echocardiography of right ventricle. OSA patients performed lung function tests and
overnight cardio-respiratory monitoring with evaluation of apnea-hypopnea index (AHI).
Results: OSA had signiﬁcantly higher body mass index and systolic blood pressure (BP) than controls. RV diame-
ters and systolic pulmonary arterial pressure (sPAP) were signiﬁcantly higher in OSA, in presence of comparable
tricuspid annular plane systolic excursion (TAPSE). OSA showed marginally lower RV global longitudinal strain
(GLS) (p b 0.05) and RV lateral wall strain (RV LLS) (p = 0.04). Three-dimensional RV ejection fraction did not
differ between the two groups. By stratifying patients according to sPAP, 18 OSA patients with sPAP
≥ 30 mm Hg had lower TAPSE (p b 0.05), RV GLS and RV LLS (both p b 0.001) than 37 patients with normal
sPAP. By separate multivariate analyses, RV GLS and RV LLS were independently associated with sPAP (both p
b 0.0001), AHI (p = 0.035 and p = 0.015 respectively) and BMI (p b 0.05 and p = 0.034) but not with age
and systolic BP in OSA.
Conclusions:A subclinical RV dysfunction is detectable by speckle tracking in OSA. The impairment of RV GLS and
RV LLS is more prominent than that of TAPSE and is evident when RVEF is still normal. GLS is independently as-
sociated with sPAP and OSA severity.
© 2017 Elsevier B.V. All rights reserved.
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1. Introduction
Obstructive sleep apnoea (OSA) is caused by the partial or total col-
lapse of the airway during sleep [1]. It is a widespread disease in western
countries population, involves all ages, it being particularly frequent in the
middle age, and its epidemiological impact is correlated to the increase of
overweight and obesity [2–4]. Anatomical and/or functional abnormali-
ties of the upper airway, ageN60years, smoking andalcohol consumption
can also promote the onset of OSA. Insulin resistance and type 2 diabetes
mellitus, arterial systemic hypertension, hormonal dysfunctions and
mixed dyslipidemia are conditions associated with OSA [1,4]. OSA is also
an independent risk factor for the development of cardiovascular and ce-
rebrovascular events, such as myocardial infarction, heart failure, heart
rhythm disturbances and conduction disorders (in particular atrial
ﬁbrillation) and stroke [5,6]. The frequent night apneas/hypopneas ex-
pose cardiovascular system to negative variations of intra-thoracic pres-
sure, leading to preload increase and hypoxia. This contributes to the
development of oxidative stress, abnormal release of catecholamines
and neurotransmitters, such as nitric oxide, which induces damage of
the vessel walls and vasoconstriction [1].
Several studies examined the chronic effect of OSA on the left ventri-
cle. In early stages, left ventricular (LV) mass increase and diastolic dys-
function with elevated LV ﬁlling pressures were detected, even in
absence of arterial hypertension [7,8]. The degree of LV diastolic dys-
function and left atrial dilation were correlated with disease severity.
Also LV systolic function resulted impaired, with an early reduction of
global longitudinal strain (GLS) and a late depression of LV ejection frac-
tion [9,10].
Conversely, few evidence is available on the impact of OSA on the
right ventricle. In this pathology, right ventricular (RV) dysfunction
could be expression of increased systolic pulmonary arterial pressure
(sPAP), rapid changes of preload during phases of apnea/hypopnea
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and hypoxic-oxidative damage [11]. New advanced technologies such
as Speckle Tracking Echocardiography (STE) [12–14] and real-time 3D
echocardiography [15–17] have already shown to be suitable in OSA
but they were never assessed together to investigate this issue. Aim of
the present study was to combine STE and 3D echo to evaluate possible
subclinical RV alterations in OSA patients.
2. Methods
2.1. Study population
The present study was conducted in accordance with the amended Declaration
of Helsinki. Local institutional review ethics committee approved the protocol
(Protocol 1129, 4 August 2015), and written informed consent was obtained from
all patients.
The study population included 59 newly diagnosed consecutive patients affected by
moderate-severe OSA but free of symptoms/signs of overt heart failure and of obstructive
and/or restrictive respiratory syndromes, consecutively referred to the Lung Diseases re-
lated sleep II Unit of Respiratory Diseases, University Federico II Hospital of Naples, Italy.
Twenty-nine healthy subjects matched for age and sex were the control group. Exclusion
criteria were: coronary artery disease and previousmyocardial infarction, more thanmild
valvular heart disease, primary cardiomyopathies, atrial ﬁbrillation.
2.2. Pulmonary evaluation
All subjects underwent pulmonary visit with lung function tests including arterial blood
gas analysis in ambient air and global spirometry according to standardized procedures [18].
Tiffenau index (normal value ≥70%)was used to exclude patientswith obstructive respirato-
ry syndromes whereas forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC)
and total lung capacity (TLC) (normal values for all three parameters ≥70%) in presence of
a normal Tiffenau index were used to exclude restrictive respiratory pathologies.
They also underwent overnight cardiorespiratory monitoring in ambient air through
the polygraph (Vital Night, Vitalaire, Rangendingen, Germany)with assessment of airﬂow
through nasal cannula, respiratory effort by thoraco-abdominal bands and oxygen satura-
tion and heart rate with pulse oximetry [19]. The number of apnoea and hypopnea lasting
N10 s per hour were used to calculate the apnea-hypopnea index (AHI): according to in-
ternational guidelines, diagnosis of OSA was made if there was an AHI N5. This index
was also used to stratify the disease severity: mild with AHI ranging between 5 and 14,
moderate with AHI between 15 and 30 and severe with AHI N30 [20].
2.3. Echocardiographic exam
Standard echo-Doppler and STE were performed by a Vivid E9 ultrasound machine
(GE Healthcare, Horten, Norway), using a 2.5 MHz transducer with harmonic capability,
according to the standards of our laboratory [21–23]. At the end of the examination
heart rate (HR) and blood pressure (BP) (mean of three measurements with aneroid
sphygmomanometer) were measured.
RV global systolic function was assessed bymeasuringM-mode derived tricuspid annu-
lar systolic excursion (TAPSE, mm). In apical 4-chamber view, pulsed Doppler RV inﬂow as-
sessmentwas recorded tomeasure early diastolic (E) and atrial (A) peak velocities (m/s) and
E/A ratio at the tips of the tricuspid leaﬂets, and pulsed Tissue Doppler of the lateral tricuspid
annulus tomeasure systolic (s′), early diastolic (e′) and atrial (a′) velocities (all in cm/s). Con-
tinuouswave (CW)Doppler of tricuspid regurgitation (TR)was utilized to calculate the pres-
sure gradient between the right ventricle and right atrium. Right atrial pressurewas assumed
by the quantitative assessment of inferior vena cava (3 or 8 or 15mmHg in relationwith size
and inspiration at rest and during forced inhalation) and this valuewas added to the peak TR
gradient to estimate sPAP according to ESC guidelines [24].
The acquisition of STE and real-time 3D echocardiography of the right ventricle was
performed according to standardized protocols [25–28]. Reliable recording of 2D images
for STE requires a high frame rate (40–70 frames/s), without dual focusing, by recording
RV cavity with the narrowest scan and at the lowest possible depth in order to display
on the screen the right ventricle as large as possible. Custom acoustic-tracking software
is interactive (endocardial-cavity interface tracedmanually and epicardial tracing generat-
ed automatically) and rejects poorly tracked segments, allowing the observer to manual
override its decision by visual assessment. The reading analysis was performed using a
semi-automated 2D strain software in a Echopac workstation (GE, Horten, Norway). Re-
gional longitudinal strain curveswere automatically generated for 6 RV regions of interest,
3 of free lateral wall and 3 of interventricular septal wall. Peak negative longitudinal strain
wasmeasured from each of the 6 segments and considered as positive (sign+) for statis-
tical analyses. RV GLS was calculated by averaging values of the 6 segments, free lateral
longitudinal strain (RV LLS) as the average of the 3 regions of interest of lateral wall and
septal longitudinal strain (RV SLS) as the average of the 3 septal regions of interest.
RV real time 3D reconstruction was obtained by a volumetric three-dimensional
transducer, with a consolidated method which has been previously described [29]. Ade-
quate 3D data sets of the right ventricle were stored digitally in raw-data format. The soft-
ware providing 3D measurements of RV function (4D-RV function, version 2.6, TomTec
Imaging Systems, Gmbh, Unterschleissheim, Germany) is clinically validated against car-
diac MRI [30,31]. Operators were required to trace endocardial border at end-diastole
and end-systole for the 3 selected RV planes. Care was taken to trace endocardial border
just outside the blood-tissue interface. Papillary muscles of tricuspid valve, moderator
band and endocardial trabeculae were included in RV cavity. These manually traced con-
tours were a requisite to initiate automated border detection algorithm. Frame-by-frame
correction of endocardial border was applied when needed. By using this methodology,
measurement of RV end-diastolic volume, end-systolic volume, ejection fraction and
stroke volumewere obtained. RV 3Dmeasurements have been demonstrated to be highly
reproducible [26].
2.4. Statistical analysis
Statistical analysis was performed by SPSS package, release 12 (SPSS Inc., Chicago, Il-
linois, USA). Data are presented asmean value± standard deviation. Descriptive statistics
was obtained by one-factor ANOVA. Linear regression analysis was performed to assess
the correlations of a single variable, obtaining value of Pearson (r) coefﬁcient. Multiple re-
gression analysis was used to identify independent associations among variables. The null
hypothesis was rejected at 2-tailed p b 0.05. Intra- and inter- observer variability of RV
strainmeasurements was assessed by calculating intra-class correlation coefﬁcients (rho).
3. Results
Clinical data of the two study groups and spirometric parameters of
OSA patients are listed in Table 1. The two groups were comparable for
sex, age and heart rate, while bodymass index (p b 0.0001) and systolic
BP (p b 0.01) were higher in OSA than in healthy controls. AHI of OSA
group varied between 6.22 and 103 and 35/59 patients (59.3%) were
classiﬁed as severe (AHI N 30) (data not in table).
The analysis of RV standard echocardiographic parameters is
summarized in Table 2. The three diameters of right ventricle
(basal, middle and longitudinal) were signiﬁcantly larger and pul-
monary arterial systolic pressure (sPAP) higher (p b 0.005) in OSA
group than in controls. sPAP range was between 10 and 64 mm Hg
(data not in table). TAPSE was not signiﬁcantly different between
the two groups.
STE and 3D analyses are also shown in Table 2. OSA patients had
lower RVGLS (p b 0.05) and RV LLS (p= 0.04) but not RV SLS than con-
trols. Three-dimensional derived RV ejection fraction did not differ sig-
niﬁcantly between the two groups. Fig. 1 depicts RV GLS in an OSAS
patient compared to a healthy control.
By subdividing OSA patients according to sPAP (Table 3), 18 patients
with sPAP ≥30 mm Hg (= pulmonary hypertension) showed lower
TAPSE (p b 0.05), RV GLS and RV LLS (both p b 0.001) than 37 patients
with sPAP b 30 mm Hg.
At univariate analyses, negative correlation of both RV GLS and RV
LLS with sPAP (r = −0.51 and r = −0.50 respectively, both p b
0.0001) and with AHI (r = −0.47, p b 0.001 and r = −0.43, p =
0.003) were observed in OSA patients. The correlations of RV GLS and
RV LLS with FVC (r= 0.29, p= 0.07 and r= 0.19, p= 0.25), forced ex-
piratory volume (r = 0.13, p = 0.42 and r = 0.02, p = 0.89) and
Tiffenau index (r =−0.18, p = 0.27 and r =−0.21, p = 0.20) were
not signiﬁcant.
By dividing OSA patients according to AHI grading, patients with the
highest AHI levels (severe OSA) showed lower RV LLS in comparison
with mild and moderate AHI (cumulative p b 0.0001) (Fig. 2) whereas
the intergroup difference of RV GLS (p = 0.291) and RV SLS (p =
0.244) were not signiﬁcant.
Two separatemultiple regression analyseswere built to identify the inde-
pendent predictors of bothRVGLS andRV LLS. In theﬁrstmodel, RVGLSwas
independentlyassociatedwith sPAP(standardizedβ coefﬁcient=−0.46,pb
0.0001), AHI (β=−0.26, p=0.035) andmarginally with bodymass index
(β=−0.24,pb 0.05), butnotwithage (β=0.18,p=0.121)andsystolicBP
(β= 0.14, p = 0.247) (cumulative R2 = 0.45, p b 0.0001). Similarly, RV
LLS was independently associated with sPAP (β=−0.44, p b 0.0001),
AHI (β= −0.30, p = 0.015) and body mass index (β= −0.26, p =
0.034), while systolic BP (β= 0.226, p = 0.07) and age (β= 0.03, p =
0.812) did not enter the model (cumulative R2 = 0.45, p b 0.0001).
The intra-class correlation coefﬁcients (rho) of RV GLS measure-
ments (n = 20, 10 normal controls and 10 OSA patients were:
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Intra-observer. RV GLS = 0.965 (95% CI = 0.911–0.986), RV LLS =
0.915 (95% CI = 0.786–0.966) and RV SLS = 0.894 (95% CI =
0.732–0.958) (all p b 0.0001).
Inter-observer. RV GLS = 0.848 (95% CI = 0.615–0.940, p b 0.0001),
RV LLS = 0.794 (95% CI = 0.480–0.919, p b 0.001) and RV SLS =
0.672 (95% CI = 0.172–0.870, p b 0.01).
4. Discussion
The present study shows that, by combining STE and 3D echo, the
latter does not provide additional information on RV damage whereas
longitudinal strain reveals RV subclinical dysfunction in OSA. In particu-
lar, our results show:
1. A mild but signiﬁcant reduction in RV GLS and RV LLS - but not RV
SLS - in OSA patients compared with healthy controls, in the ab-
sence of signiﬁcant alteration of the other echo indices of RV sys-
tolic function, such as TAPSE and 3D-derived RV ejection fraction.
2. A marginal reduction of TAPSE but a substantial impairment of RV
GLS and RV LLS in OSA patients with pulmonary arterial hyperten-
sion (sPAP ≥ 30 mm Hg) compared with those with normal sPAP.
3. Negative associations of RV GLS (and RV LLS) with PAPs and AHI,
which remained signiﬁcant even after adjusting for confounding fac-
tors, including BMI.
RV function in OSA has been poorly investigated by using standard
echocardiography. In an old report a signiﬁcant reduction of RV ejection
fraction assessed by radionuclide ventriculography was found in a het-
erogeneous group of 19 OSA patients, 18 of whom exhibited signs/
symptoms of RV heart failure [32]. Dursunoglu et al. described a reduc-
tion of RVmyocardial performance index inmoderate to severe OSA pa-
tients (AHI ≥15) [33]. In another study, RV myocardial performance
indexwas reduced inOSA, independently on the presence of arterial hy-
pertension [34].
Both STE and 3D echocardiography have been already utilized to as-
sess RV function in OSA [12–17]. Kepez et al. was the ﬁrst to highlight a
reduction in Doppler-derived RV systolic strain and strain rate in this
pathology [12]. Altekin et al. [13] showed a reduction of RV GLS in 58
OSA patients compared to healthy controls, independently on sPAP de-
gree. More recently, D'Andrea and coworkers observed lower values of
both LV and RV GLS - including RV LLS - in 55 OSA patients than in 45
controls [14]. RV LLS has been already applied in the clinical practice
to assess supranormal RV function of athletes [27] and various degrees
of heart failure [35–37]. It appears to reﬂect RV systolic function better
than RV GLS itself, since it excludes septal deformation which shares
its pattern with left ventricle [36]. Our results conﬁrm these ﬁndings
as the reduction of longitudinal deformation of OSA patients involved
RV GLS and RV LLS but not RV SLS. Of note, our reproducibility analyses
showed as both RV GLS and RV LLS are much more robust parameters
than RV SLS which showed higher intra- and inter-observer variability.
To the best of our knowledge, our study is the ﬁrst to combine STE
and 3D assessment of right ventricle inOSA. Indeed, 3D RV ejection frac-
tion did not differ from healthy controls in agreement with a previous
study [17] but in contrast with other two reports which found a signif-
icant reduction of RV ejection fraction in severe OSA patients [15,16].
Therefore, the present study points out that abnormalities of RV defor-
mation could precede those of RV chamber function in subclinical stages
of OSA.
The independent negative association we found between AHI and
both RV GLS and RV LLS is in agreement with previous reports which
tested the impact of AHI on RV strain [12,13]. Of note, RV LLSwas partic-
ularly reduced in severe (AHI N 30) and moderate OSA (AHI = 15–30)
than inmild OSA (AHI b 15). AHI is an accurate expression of OSA sever-
ity, it accounting for the number of apnea episodes per hour. It is also of
interest that our OSA patients with pulmonary hypertension did not
show signiﬁcant changes of 3D ejection fraction and only a marginal re-
duction of TAPSE whereas RV GLS and RV LLS were substantially lower
than in patients with normal sPAP. These data are in contrast with the
results of Altekin et al. [13] who did not found a signiﬁcant impact of
pulmonary hypertension on Doppler derived RV strain and strain rate
in OSA patients. This discrepancy can be at least partly explained by
the higher sPAP of our patients since we included also patients with
frankly elevated sPAP. The association between sPAP degree andRV lon-
gitudinal dysfunction of the present study was further remarked by the
independent negative association of sPAP with both RV GLS and RV LLS
in the pooled OSA group: the higher severity of pulmonary hyperten-
sion the lower RV longitudinal function.We are the ﬁrst to demonstrate
that increased RV afterload could negatively inﬂuence RV strain in this
clinical setting.
Overall, the ﬁndings of the present study suggest a direct deleterious
effect of nocturnal apneas on the right ventricle. As suggested by exper-
imental studies on mice, intermittent hypoxia – simulating the effect of
repeated nocturnal apneas - can induce repeated instantaneous epi-
sodes of RV overload though hypoxic vasoconstriction of pulmonary
Table 1
Clinical data of the two study groups and spirometric/polysomnographic data of OSA
patients.
Variable Controls (n = 29) OSA (n = 59) p value
Sex (F/M) 5/23 10/49 0.916
Age (years) 52.9 ± 10.5 54.4 ± 11.2 0.161
BMI (Kg/m2) 26.3 ± 3.4 33.2 ± 7.2 b0.0001
Systolic BP (mm Hg) 124.2 ± 11.9 133.7 ± 14.3 b0.01
Diastolic BP (mm Hg) 78.5 ± 9.7 78.9 ± 9.5 0.848
Mean BP (mm Hg) 93.7 ± 10.0 97.2 ± 10.0 0.188
Heart rate (bpm) 68.0 ± 7.7 68.8 ± 12.9 0.759
Spirometric and polysomnographic data
FVC (%) – 99.7 ± 13.7
FEV1 (%) – 102.7 ± 16.5
Tiffenau index – 82.7 ± 7.6
TLC (%) – 85.0 ± 5.3
AHI – 42.0 ± 24.3
O2 saturation (%) – 96.8 ± 1.4
AHI = apnea–hypopnoea Index, BMI = body mass index, BP = blood pressure, FVC =
forced vital capacity, FEV1 = forced expiratory volume in 1 s, OSA = obstructive sleep
apnea, TLC = total lung capacity.
Table 2
RV standard and advanced echocardiographic data.
Variable Controls (n = 29) OSA (n = 59) p value
RV basal diameter (mm) 30.2 ± 12.2 39.8 ± 5.3 b0.0001
RV mid-cavity diameter (mm) 23.1 ± 11.6 32.5 ± 6.1 b0.0001
RV longitudinal diameter (mm) 63.9 ± 9.6 68.1 ± 3.3 b0.02
TAPSE (mm) 23.3 ± 3.8 23.5 ± 3.3 0.790
Tricuspid inﬂow E/A ratio 1.18 ± 0.19 1.18 ± 0.31 0.964
Tricuspid annular s′ (cm/s) 13.5 ± 2.2 13,1 ± 2.6 0.587
Tricuspid annular e′ (cm/s) 11.2 ± 3.8 11.3 ± 3.1 0.935
Tricuspid annular a′ (cm/s) 14.8 ± 3.6 13.6 ± 3.8 0.225
sPAP (mm Hg) 23.2 ± 3.5 27.3 ± 8.1 b0.005
RV GLS (%) 22.8 ± 3.3 20.9 ± 4.9 b0.05
RV LLS (%) 25.7 ± 3.2 22.6 ± 7.2 =0.04
RV SLS (%) 19.4 ± 7.5 19.6 ± 3.9 0.877
RV EDV (ml) 110.0 ± 26.5 113.6 ± 38.3 0.613
RV ESV (ml) 49.9 ± 15.3 51.0 ± 20.4 0.793
RV EF (%) 55.5 ± 6.8 55.2 ± 7.7 0.886
RV SV (ml) 60.0 ± 16.2 63.0 ± 21.48 0.498
RV CO (l/min) 4.3 ± 1.1 4.3 ± 1.7 0.959
CO= cardiac output, EF= ejection fraction, EDV= end-diastolic volume, ESV= end-
systolic volume, GLS = global longitudinal strain, LLS = lateral longitudinal strain,
OSAS = obstructive sleep apnea syndrome, RV = right ventricular, SLS = septal lon-
gitudinal strain, SV = stroke volume, sPAP = systolic pulmonary arterial pressure,
TAPSE = tricuspid annular plane systolic excursion.
Bold remarks the statistically signiﬁcant ﬁndings.
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microcirculation. Over time, this could lead to pulmonary vascular re-
modeling and chronic pulmonary hypertension [38,39]. The higher
sPAP on our OSA patients compared with healthy controls, and the
close association found between longitudinal dysfunction and sPAP
levels support this physio-pathogenetic hypothesis. Themild but signif-
icant impact of body mass index on RV dysfunction, observed in the
multivariable model, was expectable. The association of OSA and obesi-
ty is well known [2,3]. Subclinical RV longitudinal dysfunction was pre-
viously demonstrated in obese patients [40,41]. Chronic volume
Fig. 1. Speckle-Tracking Echocardiography analysis in a normal control (top) and in an OSA patient (bottom): the right ventricle is divided in 6 segments: 3 on the free wall and 3 on the
septum. The results are also presented in a chromatic scale. In the report values of longitudinal strain considered as “positive” (sign +). Abbreviations as in Table 2.
Table 3
RV echocardiographic data in OSA patients according to sPAP.
Variable sPAP b30 mm Hg
(n = 37)
sPAP ≥30 mm Hg
(n = 18)
p value
RV basal diameter (mm) 39.4 ± 5.2 40.0 ± 4.8 0.650
RV mid-cavity diameter (mm) 32.2 ± 5.9 32.5 ± 6.6 0.835
RV longitudinal diameter (mm) 68.9 ± 8.5 66.7 ± 6.7 0.346
TAPSE (mm) 24.2 ± 2.7 22.4 ± 3.7 b0.05
Tricuspid inﬂow E/A ratio 1.20 ± 0.32 1.16 ± 0.28 0.608
Tricuspid annular s′ (cm/s) 13.2 ± 0.03 0.13 ± 0.02 0.951
Tricuspid annular e′ (cm/s) 11.6 ± 0.03 11.0 ± 0.03 0.536
Tricuspid annular a′ (cm/s) 13.7 ± 0.04 13.7 ± 0.04 0.967
RV GLS (%) 22.7 ± 4.8 18.2 ± 2.4 b0.001
RV LLS (%) 25.1 ± 7.0 17.8 ± 4.8 b0.001
RV SLS (%) 20.3 ± 4.0 18.8 ± 3.6 0.229
3DRV EDV (ml) 109.2 ± 67.5 104.8 ± 44.2 0.844
3DRV ESV (ml) 49.3 ± 31.4 47.7 ± 23.9 0.887
3DRV EF (%) 54.4 ± 9.7 53.6 ± 8.2 0.613
3DRV SV (ml) 59.9 ± 38.9 57.0 ± 24.2 0.822
3DRV CO (ml/min) 3.9 ± 2.9 4.1 ± 2.1 0.874
Abbreviations as in Table 2.
Bold remarks the statistically signiﬁcant ﬁndings.
Fig. 2. RV LLS in OSA patients according to AHI grading. Results of ANOVA with Scheffè
post-hoc intergroup comparison. Abbreviations as in Tables 1 and 2.
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overload and insulin resistance can be potential mechanisms underly-
ing this ﬁnding [42].
4.1. Study limitation
The main limitation of the present study corresponds to the lack
of a control group of obese patients with similar body mass index
but without OSA. This could have reduced the possible confounding
effect of obesity on sPAP and RV deformation. However, the associa-
tions of RV strain with both pulmonary hypertension and OSA sever-
ity were independent on the effect of overweight/obesity in the
multivariate models of our study. A further limitation could be con-
sidered the lack of information on night-time BP as we considered
BP only at the time of the echo exam. The impact of elevated night-
time BP should not be underestimated in OSA patients who require
nocturnal BP measurement to increase the accuracy of pressure
overload assessment [43].
In conclusion, the present study demonstrates that OSA patients
can exhibit a subclinical RV systolic dysfunction which is not identi-
ﬁable by simple standard echocardiography (TAPSE) and even by 3D
echocardiography (RV 3D ejection fraction). STE provides a function-
al assessment which is superior to that obtainable by TAPSE which is
a crude but less accurate index of RV longitudinal function [35,36]. It
is hypotisable that RV longitudinal dysfunction could precede the re-
duction of RV ejection fraction in subclinical stages of OSA. It is also of
interest that RV GLS impairment is independently associated with
the degree of pulmonary hypertension and in particular with the dis-
ease severity (as expressed by AHI and its grading). Based on prelim-
inary data existing on the therapeutic effect of non-invasive
ventilation on RV longitudinal function in OSA [14], it is conceivable
that patients with reduced RV strain could obtain beneﬁt by the re-
duction of pulmonary arterial pressure possibly induced by ventila-
tion therapy, particularly in those with most severe OSA showing
also the highest level of pulmonary arterial pressure.
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